Abalone Bio, an antibody company measuring large-scale activity data to drive AI-powered discovery of active therapeutics, ...

Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® ...

Cambridge, UK-based biotech start-up Maxion Therapeutics, which is developing antibody-based KnotBody drugs for ion channel- ...

Cambridge biotech Maxion Therapeutics has raised $72 million (£58m) in a Series A financing to further grow the business ...

We recently published a list of Top 10 Insider Purchases Last Month. In this article, we are going to take a look at where ...

Myrobalan Therapeutics Inc. has been awarded a grant of over $850,000 from the National Multiple Sclerosis Society to support the preclinical and translational development of MRO-002, a ...

A new review highlights how gut microbiome imbalances contribute to cardiovascular disease by altering short-chain fatty ...

Salipro Biotech has signed a research and license agreement with Boehringer Ingelheim to accelerate the development of ...

Salipro Biotech AB, a Swedish biotech company specialising in the stabilisation of challenging drug targets, today announced a research and license agreement with ...

Myrobalan to receive over $850,000 in funding to advance the development of its GPR17 antagonist for progressive MS from the ...

Researchers at Monash University have uncovered how the gut—and the food we eat—affects high blood pressure. Their discovery ...